Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jun 8;156(9):3114–3121. doi: 10.1210/en.2015-1269

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2015 by the Endocrine Society

This article has been published under the terms of the Creative Commons Attribution License (CC-BY; http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s).

PMC Copyright notice

Figure 3. — Plasma adjusted calcium, PTH, phosphate, and creatinine concentrations after ip injection of either NPS 2143 or drug vehicle. Plasma concentrations of (A–C) adjusted calcium, (D–F) PTH, (G–I) phosphate, and (J–L) creatinine were measured in untreated (U) mice, or 1, 4, or 24 hours after mice were given an ip bolus injection of control (C) or drug (D) solutions (n = 4–14 for all groups). $, P < .001 for a comparison between untreated (U) Nuf/+ or Nuf/Nuf mice and respective untreated wild-type mice. **, P < .01 and ***, P < .001 for a comparison between respective wild-type, Nuf/+, or Nuf/Nuf mice given control (C) or drug (D) solutions. †, P < .05 and ‡, P < .01 for a comparison between wild-type, Nuf/+, or Nuf/Nuf mice given control (C) or drug (D) solutions and respective untreated (U) mice.